Fig. 3
From: MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy
Receiver operating characteristics curve analysis of a radiographic evidence of progression (van der Heijde modified total Sharp score year-progression (ΔTSS) >3)) and b radiographic evidence of rapid progression (RRP), showing that serum matrix metalloproteinase-3 (MMP-3) levels measured at the outset of methotrexate monotherapy can predict radiographic evidence of non-progression of disease. AUC area under the curve